Ibrahim B. C.
- Country
- France
- Department
- Urology
Research Overview
Data & Insights
Has run more than one trial at 0 of 15 partner sites.
Specializations
Genitourinary Oncology and Sexual Health
Investigates advanced prostate cancer and therapeutic approaches for male sexual dysfunction.
- caspate-resistant prostate cancer with oligometastatic disease
- Combination of systemic agents with stereotactic radiation
- Clinical evaluation of treatments for premature ejaculation
Targets improved survival and quality of life for patients with urologic malignancies and functional concerns.
Breast Oncology
Focuses on hormone‑responsive and triple‑negative subtypes of breast cancer.
- Adjuvant endocrine therapy duration optimization
- Integration of immunotherapy in early‑stage triple‑negative disease
- Strategies to reduce relapse risk in high‑risk ER+/HER2‑ tumors
Seeks to refine curative strategies and minimize metastatic recurrence.
Head and Neck Oncology
Dedicated to squamous cell carcinoma of the head and neck, both resected and metastatic.
- Combination of novel agents with radiotherapy in high‑risk disease
- Comparative efficacy of checkpoint inhibitors with or without additional immunomodulators
- Outcomes of targeted radiation in oligometastatic settings
Advances multimodal treatment paradigms for locally advanced and recurrent disease.
Lung Oncology
Addresses therapeutic strategies for advanced non‑small cell lung cancer.
- Evaluation of PD‑1 pathway blockade in first‑line therapy
- Synergistic approaches combining immunotherapy with radiation
- Biomarker‑driven patient selection for targeted treatment
Focuses on extending survival and enhancing response durability.
Gastrointestinal Oncology
Explores treatment of gastrointestinal cancers with emphasis on chemotherapy personalization.
- Dose individualization based on enzymatic deficiency biomarkers
- Integration of fluoropyrimidine regimens with oxaliplatin
- Safety and efficacy assessments in first‑line combination protocols
Aims to optimize therapeutic index and reduce treatment‑related toxicity.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.